PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
238.00 - 242.07
140.53 - 242.25
26.77M / 38.44M (Avg.)
25.64 | 9.39
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-25.60%
Both yoy net incomes decline, with META at -64.71%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
1.28%
Less D&A growth vs. META's 10.61%, reducing the hit to reported earnings. David Dodd would confirm that core assets remain sufficient.
-232.73%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
22.90%
SBC growth well above META's 4.02%. Michael Burry would flag major dilution risk vs. competitor’s approach.
120.81%
Less working capital growth vs. META's 374.43%, indicating potentially more efficient day-to-day cash usage. David Dodd would confirm no negative impact on revenue.
140.60%
AR growth well above META's 168.41%. Michael Burry would fear inflated sales or less stringent credit controls vs. competitor.
-122.34%
Negative yoy inventory while META is 2653.37%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
-154.91%
Both negative yoy AP, with META at -172.18%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
478.16%
Lower 'other working capital' growth vs. META's 2411.03%. David Dodd would see fewer unexpected short-term demands on cash.
21.21%
Lower 'other non-cash' growth vs. META's 131.58%, indicating steadier reported figures. David Dodd would confirm no missed necessary write-downs or gains.
-7.60%
Negative yoy CFO while META is 21.13%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
34.50%
CapEx growth well above META's 12.12%. Michael Burry would suspect heavier cash outlays that risk short-term free cash flow vs. competitor.
-153.85%
Negative yoy acquisition while META stands at 63.50%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
-58.21%
Both yoy lines negative, with META at -230.65%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
50.88%
1.25-1.5x META's 41.25%. Bruce Berkowitz sees a sizable advantage unless competitor’s portfolio yields future gains.
17.24%
We have some outflow growth while META is negative at -138.10%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
21.64%
We have mild expansions while META is negative at -80.53%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
-500.00%
We cut debt repayment yoy while META is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
-100.00%
Negative yoy issuance while META is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
-14.15%
We cut yoy buybacks while META is 82.49%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.